Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Dis ; 9(5): 492, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29706648

ABSTRACT

Unintended outcomes of cancer therapy include ionizing radiation (IR)-induced stem cell depletion, diminished regenerative capacity, and accelerated aging. Stem cells exhibit attenuated DNA damage response (DDR) and are hypersensitive to IR, as compared to differentiated non-stem cells. We performed genomic discovery research to compare stem cells to differentiated cells, which revealed Phosphoprotein phosphatase 2A (PP2A) as a potential contributor to susceptibility in stem cells. PP2A dephosphorylates pATM, γH2AX, pAkt etc. and is believed to play dual role in regulating DDR and apoptosis. Although studied widely in cancer cells, the role of PP2A in normal stem cell radiosensitivity is unknown. Here we demonstrate that constitutively high expression and radiation induction of PP2A in stem cells plays a role in promoting susceptibility to irradiation. Transient inhibition of PP2A markedly restores DNA repair, inhibits apoptosis, and enhances survival of stem cells, without affecting differentiated non-stem and cancer cells. PP2Ai-mediated stem cell radioprotection was demonstrated in murine embryonic, adult neural, intestinal, and hematopoietic stem cells.


Subject(s)
Enzyme Inhibitors/pharmacology , Oxazoles/pharmacology , Protein Phosphatase 2/antagonists & inhibitors , Radiation Tolerance/drug effects , Stem Cells/drug effects , Stem Cells/radiation effects , Animals , Apoptosis , Ataxia Telangiectasia Mutated Proteins/metabolism , Cell Line, Tumor , Cells, Cultured , DNA Repair , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/enzymology , Hematopoietic Stem Cells/pathology , Hematopoietic Stem Cells/radiation effects , Humans , Male , Marine Toxins , Mice , Mice, Inbred C57BL , Mouse Embryonic Stem Cells/drug effects , Mouse Embryonic Stem Cells/enzymology , Mouse Embryonic Stem Cells/pathology , Mouse Embryonic Stem Cells/radiation effects , Neural Stem Cells/drug effects , Neural Stem Cells/enzymology , Neural Stem Cells/pathology , Neural Stem Cells/radiation effects , Protein Phosphatase 2/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , Stem Cells/enzymology , Stem Cells/pathology , Time Factors , Tissue Culture Techniques
2.
Mol Biol Cell ; 27(8): 1332-45, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-26941327

ABSTRACT

Normal tissue injury resulting from cancer radiotherapy is often associated with diminished regenerative capacity. We examined the relative radiosensitivity of normal stem cell populations compared with non-stem cells within several radiosensitive tissue niches and culture models. We found that these stem cells are highly radiosensitive, in contrast to their isogenic differentiated progeny. Of interest, they also exhibited a uniquely attenuated DNA damage response (DDR) and muted DNA repair. Whereas stem cells exhibit reduced ATM activation and ionizing radiation-induced foci, they display apoptotic pannuclear H2AX-S139 phosphorylation (γH2AX), indicating unique radioresponses. We also observed persistent phosphorylation of H2AX-Y142 along the DNA breaks in stem cells, which promotes apoptosis while inhibiting DDR signaling. In addition, down-regulation of constitutively elevated histone-3 lysine-56 acetylation (H3K56ac) in stem cells significantly decreased their radiosensitivity, restored DDR function, and increased survival, signifying its role as a key contributor to stem cell radiosensitivity. These results establish that unique epigenetic landscapes affect cellular heterogeneity in radiosensitivity and demonstrate the nonubiquitous nature of radiation responses. We thus elucidate novel epigenetic rheostats that promote ionizing radiation hypersensitivity in various normal stem cell populations, identifying potential molecular targets for pharmacological radioprotection of stem cells and hopefully improving the efficacy of future cancer treatment.


Subject(s)
Histones/metabolism , Stem Cells/metabolism , Stem Cells/radiation effects , Acetylation , Animals , Apoptosis/radiation effects , Ataxia Telangiectasia Mutated Proteins/metabolism , DNA Damage/radiation effects , DNA Repair/radiation effects , Down-Regulation/drug effects , Epigenesis, Genetic , Hepatocyte Growth Factor/metabolism , Lysine/metabolism , Male , Mice, Inbred C57BL , Phosphorylation , Proto-Oncogene Proteins/metabolism , Radiation Tolerance , Radiation, Ionizing , Stem Cells/pathology
3.
Cell Cycle ; 8(14): 2198-210, 2009 Jul 15.
Article in English | MEDLINE | ID: mdl-19502790

ABSTRACT

Chromosomes in PTEN deficient cells display both numerical as well as structural alterations including regional amplification. We found that PTEN deficient cells displayed a normal DNA damage response (DDR) as evidenced by the ionizing radiation (IR)-induced phosphorylation of Ataxia Telangiectasia Mutated (ATM) as well as its effectors. PTEN deficient cells also had no defect in Rad51 expression or DNA damage repair kinetics post irradiation. In contrast, caffeine treatment specifically increased IR-induced chromosome aberrations and mitotic index only in cells with PTEN, and not in cells deficient for PTEN, suggesting that their checkpoints were defective. Furthermore, PTEN-deficient cells were unable to maintain active spindle checkpoint after taxol treatment. Genomic instability in PTEN deficient cells could not be attributed to lack of PTEN at centromeres, since no interaction was detected between centromeric DNA and PTEN in wild type cells. These results indicate that PTEN deficiency alters multiple cell cycle checkpoints possibly leaving less time for DNA damage repair and/or chromosome segregation as evidenced by the increased structural as well as numerical alterations seen in PTEN deficient cells.


Subject(s)
Cell Cycle , DNA Repair , Genomic Instability , PTEN Phosphohydrolase/metabolism , Antineoplastic Agents, Phytogenic/pharmacology , Ataxia Telangiectasia Mutated Proteins , Caffeine/pharmacology , Cell Cycle Proteins/metabolism , Cell Line, Tumor , Chromosome Aberrations , DNA Breaks, Double-Stranded , DNA-Binding Proteins/metabolism , Humans , Infrared Rays , Karyotyping , PTEN Phosphohydrolase/deficiency , PTEN Phosphohydrolase/genetics , Paclitaxel/pharmacology , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , RNA, Small Interfering/metabolism , Rad51 Recombinase/metabolism , Telomere/metabolism , Tumor Suppressor Proteins/metabolism
4.
Methods Mol Biol ; 523: 395-410, 2009.
Article in English | MEDLINE | ID: mdl-19381924

ABSTRACT

The ataxia telangiectasia-mutated gene product (ATM), whose loss of function is responsible for ataxia telangiectasia (A-T), is a protein kinase that interacts with several substrates and is implicated in mitogenic signal transduction, chromosome condensation, meiotic recombination, cell-cycle control and telomere maintenance (Pandita, Expert Reviews in Molecular Medicine 5:1-21, 2003; Pandita, Oncogene 21:611-618, 2002; Matsuoka et al., Science 316:1160-1166, 2007). The ATM protein kinase is primarily activated in response to DNA double-strand breaks (DSBs) caused by ionizing radiation (IR) or radiomimetic drugs (Pandita et al., Oncogene 19:1386-1391, 2000). ATM is also activated by heat shock, which occurs independent of DNA damage (Hunt et al., Can Res 69:3010-3017, 2007). ATM is observed at the sites of DNA damage, where it is autophosphorylated and is dissociated from its non-active dimeric form to the active monomeric form (Bakkenist and Kastan, Nature 421:499-506, 2003). The ATM protein appears to be a part of the sensory machinery that detects DSBs during meiosis or mitosis, or breaks consequent to the damage by free radicals. Recent studies support the argument that ATM activation is regulated by chromatin modifications (Gupta, Mol Cell Biol 25:5292-5305, 2005). This review summarizes the multiple approaches used to discern the role of ATM in chromatin modification in response to DNA damage as well as heat shock.


Subject(s)
Cell Cycle Proteins/metabolism , Chromatin/metabolism , DNA Damage , DNA-Binding Proteins/metabolism , Heat-Shock Response , Molecular Biology/methods , Protein Serine-Threonine Kinases/metabolism , Tumor Suppressor Proteins/metabolism , Ataxia Telangiectasia Mutated Proteins , Cytogenetic Analysis , DNA Damage/genetics , Electrophoresis, Polyacrylamide Gel , Heat-Shock Response/genetics , Humans , Immunoblotting , Immunoprecipitation
5.
Mol Cell Biol ; 29(9): 2390-7, 2009 May.
Article in English | MEDLINE | ID: mdl-19223460

ABSTRACT

The molecular distinctions between mortality stages 1 (M1; senescence) and 2 (M2; crisis) of human replicative aging are ill defined. We demonstrate a qualitative difference between telomeric end associations at M1 and the end fusions that produce dicentric chromosomes and breakage-fusion cycles. Knockdown of ligase IV sufficient to completely inhibit radiation-induced dicentric chromosome formation had no effect on the frequency of telomere associations (TAs), establishing that TAs are not covalent conventional nonhomologous end-joining (NHEJ) products. TAs preceded and were more numerous than dicentric chromosomes. Cells initially tolerated dicentric chromosomes without dying, but eventually, a combination of too many TAs and dicentrics/complex chromosomal rearrangements resulted in apoptosis. We propose a working model in which end associations represent abortive DNA repair intermediates when the number of telomeric repeats is too small to completely inhibit DNA damage signaling but is sufficient to prevent the final covalent ligation step of NHEJ and induces the M1 checkpoint arrest in normal human cells. Rather than being all-or-none, telomere deprotection would thus proceed first through TAs before additional shortening leads to dicentric chromosomes. M2/crisis involves both qualitative changes (a shift from TAs to TAs plus dicentric chromosomes) and quantitative changes (an increase in the number of dysfunctional telomeres).


Subject(s)
Cellular Senescence/genetics , DNA Replication , Telomere/metabolism , Apoptosis/genetics , Cell Cycle/genetics , Chromosome Aberrations , DNA Damage , DNA Repair , Humans
6.
Am J Physiol Cell Physiol ; 294(3): C820-32, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18184876

ABSTRACT

This study explores the nature of K fluxes in human lens epithelial cells (LECs) in hyposmotic solutions. Total ion fluxes, Na-K pump, Cl-dependent Na-K-2Cl (NKCC), K-Cl (KCC) cotransport, and K channels were determined by 85Rb uptake and cell K (Kc) by atomic absorption spectrophotometry, and cell water gravimetrically after exposure to ouabain +/- bumetanide (Na-K pump and NKCC inhibitors), and ion channel inhibitors in varying osmolalities with Na, K, or methyl-d-glucamine and Cl, sulfamate, or nitrate. Reverse transcriptase polymerase chain reaction (RT-PCR), Western blot analyses, and immunochemistry were also performed. In isosmotic (300 mosM) media approximately 90% of the total Rb influx occurred through the Na-K pump and NKCC and approximately 10% through KCC and a residual leak. Hyposmotic media (150 mosM) decreased K(c) by a 16-fold higher K permeability and cell water, but failed to inactivate NKCC and activate KCC. Sucrose replacement or extracellular K to >57 mM, but not Rb or Cs, in hyposmotic media prevented Kc and water loss. Rb influx equaled Kc loss, both blocked by clotrimazole (IC50 approximately 25 microM) and partially by 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) inhibitors of the IK channel KCa3.1 but not by other K channel or connexin hemichannel blockers. Of several anion channel blockers (dihydro-indenyl)oxy]alkanoic acid (DIOA), 4-2(butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), and phloretin totally or partially inhibited Kc loss and Rb influx, respectively. RT-PCR and immunochemistry confirmed the presence of KCa3.1 channels, aside of the KCC1, KCC2, KCC3 and KCC4 isoforms. Apparently, IK channels, possibly in parallel with volume-sensitive outwardly rectifying Cl channels, effect regulatory volume decrease in LECs.


Subject(s)
Cell Size , Epithelial Cells/metabolism , Intermediate-Conductance Calcium-Activated Potassium Channels/metabolism , Ion Channel Gating , Lens, Crystalline/metabolism , Potassium/metabolism , Acetates/pharmacology , Blotting, Western , Bumetanide/pharmacology , Cell Line , Cell Membrane Permeability , Cell Size/drug effects , Chloride Channels/drug effects , Chloride Channels/metabolism , Clotrimazole/pharmacology , Cyclopentanes/pharmacology , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Humans , Immunohistochemistry , Indans/pharmacology , Indenes/pharmacology , Intermediate-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Intermediate-Conductance Calcium-Activated Potassium Channels/genetics , Kinetics , Lens, Crystalline/cytology , Lens, Crystalline/drug effects , Niflumic Acid/pharmacology , Nitrobenzoates/pharmacology , Osmosis , Ouabain/pharmacology , Phloretin/pharmacology , Potassium Channel Blockers/pharmacology , Pyrazoles/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Rubidium , Sodium Potassium Chloride Symporter Inhibitors , Sodium-Potassium-Chloride Symporters/metabolism , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/metabolism , Spectrophotometry, Atomic , Symporters/metabolism , Voltage-Dependent Anion Channels/drug effects , Voltage-Dependent Anion Channels/metabolism , K Cl- Cotransporters
7.
Exp Eye Res ; 83(5): 1287-94, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16949074

ABSTRACT

We recently reported potassium-chloride cotransporter activity in human lens epithelial B3 (HLE-B3) cells. The purpose of the present study was to demonstrate in these cells as well as in human lens tissue the potassium-chloride cotransport (KCC) isoforms by reverse transcriptase-polymerase chain reaction (RT-PCR), Western blotting and immunofluorescence microscopy. Of the four KCC genes known to encode the respective proteins and their spliced variants, RT-PCR with both rat and human primers revealed the predicted cDNA fragments of KCC1, KCC3a, KCC3b, and KCC4 but not KCC2 in both HLE-B3 cells and in human lens tissue extracts from cataractous patients. Polyclonal rabbit (rb) anti-rat (rt) and anti-human (hm) antibodies against rtKCC1 and hmKCC3, respectively, and a commercially available rb-anti-mouse (ms) KCC4 antibody were used. Rb anti-rtKCC1-ECL3 [against epitopes within the large extracellular loop 3 (ECL3)] revealed a 150kDa band in HLE-B3 cells consistent with the known molecular weight of KCC1. Rb anti-hmKCC3-ECL3 yielded three bands of 150, 122 and 105kDa, evidence for the presence of KCC3a, KCC3b and possibly KCC3c isoforms. The 122 and 112kDa bands were also demonstrated by rb anti-hmKCC3-CTD [the C-terminal domain (CTD)]. Rb anti-msKCC4 antibody only showed a 100kDa band in HLE-B3 cells. In the human lens tissues, a 115kDa protein was detected with rb anti-rtKCC1-ECL3 and a 100kDa band with rb anti-msKCC4, however, no bands with rb anti-hmKCC3-ECL3 or rb anti-hmKCC3-CTD. Fluorescence microscopy revealed immunocytochemical cytoplasmic and membrane labeling of HLE-B3 cells with anti-KCC1, -KCC3 (laser confocal microscopy) and -KCC4 antibodies and a Cy3-tagged secondary antibody. Hence HLE-B3 cells expressed proteins of the KCC1, KCC3a, b, and KCC4 isoforms, whereas surgically removed cataractous lens tissue expressed only those of KCC1 and KCC4.


Subject(s)
Eye Proteins/metabolism , Lens, Crystalline/chemistry , Symporters/metabolism , Blotting, Western/methods , Cell Line , Chlorides/metabolism , Eye Proteins/analysis , Humans , Immunochemistry/methods , Immunohistochemistry/methods , Isomerism , Membrane Proteins/metabolism , Microscopy, Confocal , Microscopy, Fluorescence/methods , Potassium/metabolism , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Symporters/analysis , Tissue Extracts/chemistry , K Cl- Cotransporters
8.
Cell Physiol Biochem ; 16(1-3): 87-98, 2005.
Article in English | MEDLINE | ID: mdl-16121037

ABSTRACT

Sheep K-Cl cotransporter-1(shKCC1) cDNA was cloned from kidney by RT-PCR with an open reading frame of 3258 base pairs exhibiting 92%, 90%, 88% and 87% identity with pig, rabbit and human, rat and mouse KCC1 cDNAs, respectively, encoding an approximately 122 kDa polypeptide of 1086-amino acids. Hydropathy analysis reveals the familiar KCC1 topology with 12 transmembrane domains (TMDs) and the hydrophilic NH2-terminal (NTD) and COOH-terminal (CTD) domains both at the cytoplasmic membrane face. However, shKCC1 has two rather than one large extracellular loops (ECL): ECL3 between TMDs 5 and 6, and ECL6, between TMDs 11 and 12. The translated shKCC1 protein differs in 12 amino acid residues from other KCC1s, mainly within the NTD, ECL3, ICL4, ECL6, and CTD. Notably, a tyrosine residue at position 996 replaces aspartic acid conserved in all other species. Human embryonic kidney (HEK293) cells and mouse NIH/3T3 fibroblasts, transiently transfected with shKCCI-cDNA, revealed the glycosylated approximately 150 kDa proteins by Western blots and positive immunofluorescence-staining with polyclonal rabbit anti-ratKCC1 antibodies. ShKCC1 was functionally expressed in NIH/3T3 cells by an elevated basal Cl-dependent K influx measured with Rb as K-congener that was stimulated three-fold by the KCC-activator N-ethylmaleimide.


Subject(s)
Kidney/metabolism , Sheep/genetics , Symporters/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Chlorides/metabolism , Cloning, Molecular , DNA, Complementary/genetics , Gene Expression , Humans , In Vitro Techniques , Mice , Molecular Sequence Data , NIH 3T3 Cells , Potassium/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Sheep/metabolism , Species Specificity , Symporters/chemistry , Symporters/metabolism , K Cl- Cotransporters
SELECTION OF CITATIONS
SEARCH DETAIL
...